Construction of an Immune-Associated Gene-Based Signature in Muscle-Invasive Bladder Cancer

Table 1

TCGA and our MIBC patient characteristics.

Clinical characteristics		TCGA ()	%	Our samples ()	%
Survival status	Alive	107	65.24	9	90
	Dead	57	34.76	1	10
Age at diagnosis		68 (34-87)		64 (48-77)
Gender	Female	39	23.78	2	20
	Male	125	76.22	8	80
Histologic grade	High grade	148	90.24	5	50
	Low grade	16	9.76	5	50
Stage	I	0	0	0	0
	II	49	29.88	2	20
	III	63	38.41	4	40
	IV	52	31.71	4	40
Pathologic_T	T1	0	0	0	0
	T2	55	33.54	2	20
	T3	86	52.44	7	70
	T4	23	14.02	1	10
Pathologic_M	M0	157	95.73	9	90
	M1	7	4.27	1	1
Pathologic_N	N0	115	70.12	8	80
	N1	20	12.20	1	10
	N2	27	16.46	1	10
	N3	2	1.22	0	0
Histological subtype	Nonpapillary	103	62.8	2	20
	Papillary	61	37.2	8	80